Unjoni Ewropea - Malti - EMA (European Medicines Agency)

clinuvel europe limited - afamelanotide - protoporphyria, eritropoetika - emolljenti u protettivi - prevenzjoni ta 'fototossiċità f'pazjenti adulti bi protoporfija eritropojetika (epp).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - preparazzjonijiet oħra dermatoloġiċi - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - bimatoprost - glaucoma, open-angle; ocular hypertension - prostaglandin analogues, ophthalmologicals - tnaqqis ta 'pressjoni intraokulari elevata f'glawkoma kronika ta' angolu miftuħ u pressjoni għolja fl-għajnejn (bħala monoterapija jew bħala terapija aġġuntiva għal imblokkaturi tar-riċetturi beta).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - oftalmoloġiċi - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - bimatoprost, timolol - glaucoma, open-angle; ocular hypertension - oftalmoloġiċi - it-tnaqqis tal-pressjoni intraocular (iop) fil-pazjenti bil-miftuħ-angolu glaucoma jew ipertensjoni okulari li huma responsivi biżżejjed biex beta-blockers topika jew analogi prostaglandin.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

vanda pharmaceuticals netherlands b.v. - tasimelteon - disturbi fl-irqad, rhythm circadian - psikolettiċi - hetlioz huwa indikat għall-kura ta 'mhux-24-hour sleep-wake disorder (mhux-24) f'adulti totalment għomja.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

bausch + lomb ireland limited - bromfenac sodium sesquihydrate - pain, postoperative; ophthalmologic surgical procedures - oftalmoloġiċi - kura ta 'infjammazzjoni okulari wara l-operazzjoni wara l-estrazzjoni tal-katarretti fl-adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep inizjattiva u maintenance disorders - psikolettiċi - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

mylan ireland limited - lenalidomide - majloma multipla - immunosoppressanti - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

mylan pharmaceuticals limited - cinacalcet hydrochloride - hyperparathyroidism, secondary; hypercalcemia - homeostasi tal-kalċju - il-kura ta 'iperparatirojdiżmu sekondarju (hpt) f'pazjenti b'mard renali fl-aħħar stadju (esrd) fuq terapija ta' dijalisi ta 'manteniment. cinacalcet mylan jista 'jintuża bħala parti minn kors terapewtiku li jinkludi binders tal-fosfat u/jew sterols ta' vitamina d, kif xieraq. tnaqqis ta 'iperkalċimja f'pazjenti b': - paratirojde carcinomaprimary hpt li għalihom parathyroidectomywould tkun indikata fuq il-bażi tal-livelli tal-kalċju fis-serum (kif definit mil-linji gwida ta ' kura rilevanti), iżda fejn paratirojdektomija mhiex klinikament xierqa jew kontraindikata.